This suggests that CD28+PD-1+ Tc cells may downregulate CLEC2C expression, thereby impacting KLRB1 expression in CD4+ T cells and contributing to immune dysfunction within the HCC microenvironment. The gene discussed is KLRB1; the disease is hepatocellular carcinoma.